CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Return 73.3%
This Quarter Return
-2.2%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
10 Year Return
AUM
$1.47B
AUM Growth
-$30.5M
Cap. Flow
+$67.4M
Cap. Flow %
4.6%
Top 10 Hldgs %
63.82%
Holding
43
New
4
Increased
16
Reduced
5
Closed
8
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ORIC icon
26
Oric Pharmaceuticals
ORIC
$1.06B
$14.1M 0.97%
2,000,000
APGE icon
27
Apogee Therapeutics
APGE
$2.26B
$11.4M 0.78%
290,000
CABA icon
28
Cabaletta Bio
CABA
$155M
$8.23M 0.56%
1,100,000
PCSC
29
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
$117M
$7.55M 0.52%
+750,000
New +$7.55M
NGNE icon
30
Neurogene
NGNE
$285M
$7.28M 0.5%
200,000
VTGN icon
31
VistaGen Therapeutics
VTGN
$109M
$5.48M 0.37%
1,575,000
BBOT
32
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$784M
$5.11M 0.35%
500,000
AUTL
33
Autolus Therapeutics
AUTL
$389M
$4.1M 0.28%
1,178,723
-1,121,277
-49% -$3.9M
ORKA
34
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
$1.59M 0.11%
+34,527
New +$1.59M
AVTX icon
35
Avalo Therapeutics
AVTX
$153M
$499K 0.03%
+40,000
New +$499K
ACET icon
36
Adicet Bio
ACET
$60M
-1,374,320
Closed -$3.23M
ADVM icon
37
Adverum Biotechnologies
ADVM
$73.9M
-657,333
Closed -$9.29M
DBVT
38
DBV Technologies
DBVT
$245M
-9,269
Closed -$69.4K
ENGN icon
39
enGene Holdings
ENGN
$265M
-1,250,000
Closed -$21.2M
MGNX icon
40
MacroGenics
MGNX
$126M
-295,020
Closed -$4.34M
SABS icon
41
SAB Biotherapeutics
SABS
$23.6M
-183,174
Closed -$832K
KYTX icon
42
Kyverna Therapeutics
KYTX
$170M
-912,189
Closed -$22.7M
ALPN
43
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
-1,375,000
Closed -$54.5M